• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: Special Considerations in HIV Management

Podcast

A panel of experts in infectious disease and managed care to discuss management of HIV, including the need for individualized care and the role for newer treatments options.

At the beginning of the year, The American Journal of Managed Care® convened a panel of experts in infectious disease and managed care to discuss management of HIV, including the need for individualized care and the role for newer treatments options. Here, we provide some of that conversation.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Watch the full discussion:

Special Considerations in HIV Management

Listen above or through one of these podcast services:

Related Videos
Dr Guru Sonpavde
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Related Content
FDA logo on textured paper | Image credit: Araki Illustrations - stock.adobe.com

FDA Grants Priority Review to Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

December 2nd 2023
Article

Positive data from the phase 3 EV-302 trial of enfortumab vedotin with pembrolizumab in locally advanced or metastatic urothelial cancer have shifted the landscape.

Read More

Managed Care Cost podcast logo on white background

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

November 30th 2023
Podcast

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

Contributor: Reflections on World AIDS Day 2023—A Call to Increase Research Funding on HIV and Aging

Contributor: Reflections on World AIDS Day 2023—A Call to Increase Research Funding on HIV and Aging

December 1st 2023
Article

Research on HIV and aging should be the focus of future research as World AIDS Day brings the chronic illness to the forefront.

Read More

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

November 21st 2023
Podcast

In part 2 of this 2-part podcast, a panel of experts discusses implementation biosimilars in biologic-naïve patients, auto-substitution, and more.

Listen

Vitamin D | Image credit: Cozine – stock.adobe.com

Vitamin D Linked to Clinical, Endoscopic Outcomes of Vedolizumab Treatment for IBD

November 30th 2023
Article

Pretreatment vitamin D levels were associated with endoscopic improvement in patients with ulcerative colitis and decreased C-reactive protein levels in patients with Crohn disease.

Read More

Psoriasis skin, eczema, rash and other skin diseases. A woman hides her face, she is ashamed of her autoimmune genetic disease. Imperfect beauty. | Image credit: stockmaster - stock.adobe.com.jpg

Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available

November 30th 2023
Article

Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.

Read More

© 2023 MJH Life Sciences
AJMC®
All rights reserved.